Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
Diabetes, Obesity & Metabolism|April 1, 2024
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated databaseMatthew Anson, Alex E Henney, Sizheng S Zhao, et al.
BMC Medicine|December 4, 2024
The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort studyMatthew Anson, Jun Shang Poon, Alex E Henney, et al.
Diagnostics (Basel, Switzerland)|January 27, 2021
Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve FibresJamie Burgess, Bernhard Frank, Andrew Marshall, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 2, 2024
Metabolic syndrome traits differentially and cumulatively influence micro- and macrovascular disease risk in patients with MASLDAlex E Henney, David R Riley, Theresa J Hydes, et al.
Diabetes, Obesity & Metabolism|July 8, 2026
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level SynthesisMatthew Anson, Ahmed Iqbal, Shazli Azmi, et al.
Investigative Ophthalmology & Visual Science|March 19, 2015
The Inferior Whorl For Detecting Diabetic Peripheral Neuropathy Using Corneal Confocal MicroscopyIoannis N Petropoulos, Maryam Ferdousi, Andrew Marshall, et al.
Oncology and Therapy|October 16, 2021
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and TreatmentJamie Burgess, Maryam Ferdousi, David Gosal, et al.
Diabetologia|November 22, 2021
Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetesFrank G Preston, Yanda Meng, Jamie Burgess, et al.
Diabetes, Obesity & Metabolism|November 12, 2024
The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomesDavid R Riley, Alex Henney, Matthew Anson, et al.
BMC Endocrine Disorders|October 1, 2024
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studiesKatarzyna Nabrdalik, Mirela Hendel, Krzysztof Irlik, et al.
Pageof 19